Split History
ETFs Holding ALT »    ALT Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Altimmune is a clinical stage immunotherapeutics company focused on the discovery and development of products to stimulate immune responses for the prevention and treatment of diseases. Co.'s product candidates include: HepTcell, an immunotherapeutic for patients infected with the hepatitis B virus; ALT-702, a tumor immunostimulant designed to elicit or improve immune responses to cancers; NasoVAX, an intranasally administered recombinant influenza vaccine which stimulates an immune response; NasoShield, an anthrax vaccine designed to provide protection after a single intranasal administration; and SparVax-L, a recombinant protein-based anthrax vaccine designed to require fewer doses. According to our ALT split history records, Altimmune has had 1 split.
ALT split history picture
Altimmune (ALT) has 1 split in our ALT split history database. The split for ALT took place on September 14, 2018. This was a 1 for 30 reverse split, meaning for each 30 shares of ALT owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 33.3333333333333 share position following the split.

When a company such as Altimmune conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the ALT split history from start to finish, an original position size of 1000 shares would have turned into 33.3333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Altimmune shares, starting with a $10,000 purchase of ALT, presented on a split-history-adjusted basis factoring in the complete ALT split history. ALT split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/07/2010
End date: 07/06/2020
Start price/share: $1,484.70
End price/share: $9.93
Dividends collected/share: $0.00
Total return: -99.33%
Average Annual Total Return: -39.38%
Starting investment: $10,000.00
Ending investment: $66.83
Years: 10.01
Date Ratio
09/14/20181 for 30
ALT is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ALXA Split History
ALXN Split History
AMDA Split History
AMED Split History
AMGN Split History
AMN Split History
AMPE Split History
AMRI Split History
AMRN Split History
AMSG Split History

Also explore: ALT shares outstanding history

Altus Midstream Company (ATLM)
FS KKR Capital Corp. (FSK)
Groupon (GRPN)
XpresSpa Group, Inc. (XSPA)
Energy Focus, Inc. (EFOI)
The Cushing NextGen Infrastructure Income Fund (SZC)
Teligent, Inc. (TLGT)
Laredo Petroleum, Inc. (LPI)
Global Eagle Entertainment Inc. (ENT)
ToughBuilt Industries, Inc. (TBLT)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

ALT Insider Buying

ALT Split History | www.SplitHistory.com | Copyright © 2013 - 2020, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.